PWAM
TGTX icon

Private Wealth Asset Management’s TG Therapeutics TGTX Stock Holding History

Private Wealth Asset Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.06K Hold
165
– – ﹤0.01% 722
2026
Q1 		$5.48K Hold
165
– – ﹤0.01% 774
2025
Q4 		$4.92K Hold
165
– – ﹤0.01% 764
2025
Q3 		$5.96K Sell
165
-850
-84% -$28K ﹤0.01% 738
2025
Q2 		$36.5K Buy
+1,015
New +$37.8K ﹤0.01% 438

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Private Wealth Asset Management's TGTX Position: Q2 2026 in Review

Private Wealth Asset Management held its TG Therapeutics (TGTX) position steady in Q2 2026 at 165 shares worth $9.06K. The position accounts for ﹤0.01% of the portfolio, ranked #722.

Private Wealth Asset Management first reported a position in TGTX in Q2 2025 and has held it in 5 quarters since. The position peaked at $36.5K in Q2 2025. 429 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Private Wealth Asset Management held 165 shares of TG Therapeutics worth $9.06K as of Q2 2026.
  • Private Wealth Asset Management left its TG Therapeutics share count unchanged in Q2 2026.
  • TG Therapeutics made up ﹤0.01% of Private Wealth Asset Management's portfolio in Q2 2026, its #722 holding.
  • Private Wealth Asset Management first reported a position in TG Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Private Wealth Asset Management's TG Therapeutics position peaked at $36.5K in Q2 2025.
  • 429 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Private Wealth Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.